Skip to main content

. 1988 Sep 17;297(6650):741–742. doi: 10.1136/bmj.297.6650.741-f

Systemic hypertension in patients receiving dipivalyl adrenaline for glaucoma.

M E Nelson ¹, A Z Andrzejowski ¹

PMCID: PMC1834117 PMID: 3147756

741

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kerr C. R., Hass I., Drance S. M., Walters M. B., Schulzer M. Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma. Br J Ophthalmol. 1982 Feb;66(2):109–114. doi: 10.1136/bjo.66.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kohn A. N., Moss A. P., Hargett N. A., Ritch R., Smith H., Jr, Podos S. M. Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma. Am J Ophthalmol. 1979 Feb;87(2):196–201. doi: 10.1016/0002-9394(79)90142-9. [DOI] [PubMed] [Google Scholar]
Wandel T., Spinak M. Toxicity of dipivalyl epinephrine. Ophthalmology. 1981 Mar;88(3):259–260. doi: 10.1016/s0161-6420(81)35042-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES